Literature DB >> 1697111

A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.

R E Morris1, J Wu, R Shorthouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697111

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

Review 1.  [Immunomodulation in penetrating keratoplasty. Current status and perspectives].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.

Authors:  R Li; D Gage; R McKallip; S Ladisch
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  Inhibition of T and B lymphocyte proliferation by rapamycin.

Authors:  J E Kay; L Kromwel; S E Doe; M Denyer
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

Review 4.  Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.

Authors:  Jeffrey P MacKeigan; Darcy A Krueger
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

5.  Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.

Authors:  M J Fealy; W S Umansky; K D Bickel; J J Nino; R E Morris; B H Press
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

6.  Rapamycin inhibits airway leukocyte infiltration and hyperreactivity in guinea pigs.

Authors:  J N Francischi; D Conroy; K Maghni; P Sirois
Journal:  Agents Actions       Date:  1993

7.  Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.

Authors:  I Joffe; I Katz; S Sehgal; F Bex; Y Kharode; J Tamasi; S Epstein
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

8.  Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2.

Authors:  Kerrington R Molhoek; Chantel C McSkimming; Walter C Olson; David L Brautigan; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2008-10-08       Impact factor: 6.968

9.  Rapamycin ameliorates experimental autoimmune uveoretinitis by inhibiting Th1/Th2/Th17 cells and upregulating CD4+CD25+ Foxp3 regulatory T cells.

Authors:  Li-Fei Yuan; Guang-Da Li; Xin-Jun Ren; Hong Nian; Xiao-Rong Li; Xiao-Min Zhang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

10.  ScFKBP12 bridges rapamycin and AtTOR in Arabidopsis.

Authors:  Rui Zhang; Zhigang Meng; Tao Zhou; Yong Deng; Li Feng; Yuan Wang; Guoqing Sun; Sandui Guo; Maozhi Ren
Journal:  Plant Signal Behav       Date:  2013-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.